Texas Attorney General Ken Paxton Sues Tylenol Makers for Autism Allegations
Texas Attorney General Ken Paxton has filed a lawsuit against the manufacturers of Tylenol, alleging that they concealed dangers linked to the drug and its potential effects on children’s brain development. This legal action follows recent comments from former President Donald Trump, who suggested a connection between Tylenol use during pregnancy and autism.
Details of the Lawsuit Against Tylenol Makers
The lawsuit targets Johnson & Johnson and Kenvue, the company currently producing Tylenol. Paxton accuses these firms of profiting from pain relief while disregarding safety concerns. He stated that they have “betrayed America” by prioritizing profits over public health.
Kenvue has responded firmly, claiming there is no credible evidence linking Tylenol to autism. Their official statement emphasized that they are concerned about the spread of misinformation regarding the drug’s safety, which could jeopardize the health of women and children in the U.S.
Professional Support for Tylenol’s Safety
- The American College of Obstetricians and Gynecologists supports the use of acetaminophen for treating pain and fever in pregnant women.
- They assert that extensive research has not indicated that acetaminophen causes neurodevelopmental disorders.
Despite the lawsuit, the FDA has also clarified that a definitive causal relationship between Tylenol and autism has not been proven. Health Secretary Robert F. Kennedy Jr. has announced plans for extensive testing to explore the causes of autism.
Citing Public Figures and Statements
Paxton’s lawsuit references statements made by Trump, who raised concerns about Tylenol use during pregnancy. This commentary led to heightened scrutiny by public health officials. Last month, Trump urged pregnant women to refrain from using the medication, prompting a notice from the FDA to reconsider its use.
The Broader Context
This lawsuit coincides with actions taken by a group of parents who filed a similar complaint in 2022 against Tylenol makers, alleging links to autism and ADHD. That case was dismissed by a federal judge, who found the evidence presented by the parents was inconclusive.
As the legal battle unfolds, it raises significant questions about the safety of acetaminophen during pregnancy and its implications for public health. The outcome of this lawsuit could influence how pain relief options for pregnant women are perceived and utilized in the future.
